Pharmacology And Chemistry
-
Vanderbilt-Ancora partnership advances research for rare form of epilepsy
Research in the Weaver lab leads to discoveries that help secure partnership with Ancora Innovation LLC. “Vanderbilt is at the forefront of genetic research. By understanding the genetic causes of disease opens exciting new opportunities to develop drugs to treat them more effectively,” said Matt Nelson, vice president, genetics and genomics, 3DC at Deerfield Management. Read MoreOct 27, 2022